XML 36 R23.htm IDEA: XBRL DOCUMENT v3.19.2
Balance Sheet Account Detail (Tables)
 6 Months Ended
Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cash, Cash Equivalents and Investments
The following is a summary of our presented composition of “cash and cash equivalents” and “marketable securities”:
 
 
 
 
 
 
 
 
 
 
 
 
 
Historical or Amortized Cost
 
Foreign Currency Translation
 

Unrealized
Gains
 

Fair
Value
 
Cash and Cash
Equivalents
 
Marketable Securities
 
June 30, 2019
 
 

 
 
 
 
 
 
 
 
 
Equity securities* (see Note 7)
$
8,710

 
$
(4,678
)
 
$
28,121

 
$
32,153

 
$
—

 
$
32,153


Money market funds
72,384

 
—

 
—

 
72,384

 
72,384

 
—

 
Government-related debt securities**
104,440





95


104,535


7,497


97,038


Corporate debt securities**
39,818

 
—

 
25

 
39,843

 
15,484

 
24,359


Bank deposits
22,886

 
—

 
—

 
22,886

 
22,886

 
—

 
Bank CDs
6,571

 
—

 
13

 
6,584

 
—

 
6,584

 
Total cash and cash equivalents and marketable securities
$
254,809

 
$
(4,678
)
 
$
28,254

 
$
278,385

 
$
118,251

 
$
160,134

 
December 31, 2018
 
 

 
 
 
 
 
 
 
 
 
Equity securities* (see Note 7)
$
8,710

 
$
(2,168
)
 
$
39,880

 
$
46,422

 
$
—

 
$
46,422

 
Money market funds
142,745

 
—

 
—

 
142,745

 
142,745

 
—

 
Bank deposits
14,735

 
—

 
—

 
14,735

 
14,735

 
—

 
Bank CDs
86

 
—

 
—

 
86

 
—

 
86

 
Total cash and cash equivalents and marketable securities
$
166,276

 
$
(2,168
)
 
$
39,880

 
$
203,988

 
$
157,480

 
$
46,508

 

* Beginning January 1, 2018, under the requirements of ASU 2016-01, Recognition and Measurement of Financial Assets and Liabilities, the unrealized gain (loss) on our CASI equity securities are recognized as an increase (decrease) to “other income (expense), net” on the Condensed Consolidated Statements of Operations (rather than through “other comprehensive income (loss)” on the Condensed Consolidated Statements of Comprehensive (Loss) Income). Our adoption of ASU 2016-01 on January 1, 2018 resulted in a $17.2 million cumulative-effect adjustment, net of income tax, reported as a decrease to “accumulated other comprehensive loss” and a decrease to “accumulated deficit” on the accompanying Condensed Consolidated Balance Sheets. Our unrealized gain (loss) on these equity securities for the three and six months ended June 30, 2019 was $0.4 million and $(11.8) million, respectively, as reported in “other income (expense), net” on the accompanying Condensed Consolidated Statements of Operations.
** Beginning in the second quarter of 2019, we purchased government and corporate debt securities. We have classified these as “available-for-sale” since we may redeem or sell these investments before their stated maturity to fund our operations. Under the requirements of ASC 320, Investments - Debt and Equity Securities: (i) we record these securities at initial “book value” and then amortize, through maturity, the determined “discount” or “premium” within “interest income” on the accompanying Condensed Consolidated Statements of Operations, and (ii) we recognize the “unrealized gains” of these securities (i.e., June 30, 2019 fair value versus amortized book value) as a separate component of “accumulated other comprehensive income (loss)” on the accompanying Condensed Consolidated Statements of Comprehensive (Loss) Income for the three and six months ended June 30, 2019.
Schedule of Property and Equipment Net of Accumulated Depreciation
“Property and equipment, net of accumulated depreciation” consists of the following: 
 
June 30, 2019
 
December 31, 2018
Manufacturing equipment*
$
3,654

 
$
—

Computer hardware and software
3,449

 
3,079

Laboratory equipment
670

 
635

Office furniture
335

 
212

Leasehold improvements
2,957

 
2,957

Property and equipment, at cost
11,065

 
6,883

(Less): Accumulated depreciation
(6,531
)
 
(6,498
)
Property and equipment, net of accumulated depreciation
$
4,534

 
$
385
Prepaid Expenses and Other Assets
“Prepaid expenses and other assets” consists of the following:
 
June 30, 2019
 
December 31, 2018
Deposits
$
10,549

 
$
6,792

Prepaid insurance
290

 
782

Prepaid expenses and other assets
$
10,839

 
$
7,574
Schedule of Other Receivables
“Other receivables” consists of the following:
 
June 30, 2019
 
December 31, 2018
Insurance receivable*
$
5,674

 
$
206

Other miscellaneous receivables (including Medicaid rebate credits and royalty receivables from licensees)
1,926

 
1,189

Secured promissory note (see Note 7)
1,528

 
1,525

Income tax receivable - current portion
632

 
643

Interest receivable from marketable securities (see Note 3(a))
414


—

Reimbursements due from development partners for incurred research and development expenses
55

 
135

Other receivables
$
10,229

 
$
3,698


*This insurance receivable balance represents legal fees and pending settlement offers that are expected to be reimbursed by our insurance carriers.
Summary of Other Assets
“Other assets” consists of the following: 
 
June 30, 2019
 
December 31, 2018
Key employee life insurance – cash surrender value associated with deferred compensation plan (Note 9(f))
$
7,410

 
$
6,274

Income tax receivable - non-current portion*
668

 
668

Research & development supplies and other
199

 
246

Other assets
$
8,277

 
$
7,188

* This value represents the non-current portion of the refundable alternative minimum tax credit that is expected to be received over the next few years (see Note 10).
Assets And Liabilities, Leases
“Facility and equipment under lease” consists of the following:

June 30, 2019

December 31, 2018
Office and research facilities
$
3,379


$
—

Office equipment
463


—

Facility and equipment under lease (Note 9(a))
$
3,842


$
—



The below table summarizes these lease asset and liability accounts presented on our accompanying Condensed Consolidated Balance Sheets:
Operating Leases*
 
Condensed Consolidated Balance Sheet Caption
 
Balance as of June 30, 2019
Operating lease right-of-use assets - non-current
 
Facility and equipment under lease
 
$
3,842


 

 

Operating lease liabilities - current
 
Accounts payable and other accrued liabilities
 
$
642

Operating lease liabilities - non-current
 
Other long-term liabilities
 
3,429

     Total operating lease liabilities
 

 
$
4,071

* As of June 30, 2019, we have no “finance leases” as defined in Topic 842.
Schedule of Accounts Payable and Other Accrued Liabilities
“Accounts payable and other accrued liabilities” consists of the following:
 
June 30, 2019
 
December 31, 2018
Trade accounts payable and other
$
33,593

 
$
44,919

Lease liability - current portion (Note 9(a))
642


—

Accrued commercial/Medicaid rebates
3,526

 
8,371

Accrued product royalty due to licensors
235

 
4,337

Allowance for product returns
5,309

 
5,171

Accrued data and distribution fees
753

 
3,248

Accrued GPO administrative fees
29

 
296

Accrued inventory management fees
368

 
388

Allowance for government chargebacks
—

 
2,730

Accounts payable and other accrued liabilities
$
44,455

 
$
69,460
Schedule of Amounts Presented in Accounts Payable and Other Accrued Liabilities
Amounts presented within “accounts payable and other accrued liabilities” in the accompanying Condensed Consolidated Balance Sheets for our categories of GTN estimates (see Note 2(i)) were as follows:

Commercial/Medicaid Rebates and Government Chargebacks
 
Distribution, Data, Inventory and
GPO Administrative Fees
 
Product Return Allowances
Balance as of December 31, 2017
$
10,358

 
$
5,727

 
$
4,045

Add: GTN accruals recorded for product sales
65,751

 
13,962

 
1,700

(Less): Payments made and credits against GTN accruals
(65,008
)
 
(15,757
)
 
(574
)
Balance as of December 31, 2018
$
11,101

 
$
3,932

 
$
5,171

Add: GTN accruals recorded for product sales
7,252

 
1,197

 
250

(Less): Payments made and credits against GTN accruals
(14,827
)
 
(3,979
)
 
(112
)
Balance as of June 30, 2019
$
3,526

 
$
1,150

 
$
5,309
Deferred Revenue, by Arrangement, Disclosure
“Contract liabilities” consists of the following:

June 30, 2019
 
December 31, 2018
Customer deposit for EVOMELA supply in China territory (see Note 7)
$
7,245


$
4,850

Contract liabilities
$
7,245

 
$
4,850
Summary of Other Long-Term Liabilities “Other long-term liabilities” consists of the following:
 
June 30, 2019
 
December 31, 2018
Deferred compensation liability (Note 9(f))
$
7,318

 
$
5,474

Lease liability - non-current portion (Note 9(a))
3,429

 
—

Other tax liabilities
176

 
176

Other long-term liabilities
$
10,923

 
$
5,650